These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 36791893)
21. Role of acyl-CoA synthetase ACSL4 in arachidonic acid metabolism. Kuwata H; Hara S Prostaglandins Other Lipid Mediat; 2019 Oct; 144():106363. PubMed ID: 31306767 [TBL] [Abstract][Full Text] [Related]
22. A role for long-chain acyl-CoA synthetase-4 (ACSL4) in diet-induced phospholipid remodeling and obesity-associated adipocyte dysfunction. Killion EA; Reeves AR; El Azzouny MA; Yan QW; Surujon D; Griffin JD; Bowman TA; Wang C; Matthan NR; Klett EL; Kong D; Newman JW; Han X; Lee MJ; Coleman RA; Greenberg AS Mol Metab; 2018 Mar; 9():43-56. PubMed ID: 29398618 [TBL] [Abstract][Full Text] [Related]
23. ACSL4 reprograms fatty acid metabolism in hepatocellular carcinoma via c-Myc/SREBP1 pathway. Chen J; Ding C; Chen Y; Hu W; Yu C; Peng C; Feng X; Cheng Q; Wu W; Lu Y; Xie H; Zhou L; Wu J; Zheng S Cancer Lett; 2021 Apr; 502():154-165. PubMed ID: 33340617 [TBL] [Abstract][Full Text] [Related]
24. Anti-neuroinflammatory effects of DPTP, a novel synthetic clovamide derivative in in vitro and in vivo model of neuroinflammation. Lim HW; Park JI; More SV; Park JY; Kim BW; Jeon SB; Yun YS; Park EJ; Yoon SH; Choi DK Brain Res Bull; 2015 Mar; 112():25-34. PubMed ID: 25596423 [TBL] [Abstract][Full Text] [Related]
25. Natural bear bile powder suppresses neuroinflammation in lipopolysaccharide-treated mice via regulating TGR5/AKT/NF-κB signaling pathway. Zhu H; Wang G; Bai Y; Tao Y; Wang L; Yang L; Wu H; Huang F; Shi H; Wu X J Ethnopharmacol; 2022 May; 289():115063. PubMed ID: 35149130 [TBL] [Abstract][Full Text] [Related]
26. MicroRNA-124 regulates the expression of MEKK3 in the inflammatory pathogenesis of Parkinson's disease. Yao L; Ye Y; Mao H; Lu F; He X; Lu G; Zhang S J Neuroinflammation; 2018 Jan; 15(1):13. PubMed ID: 29329581 [TBL] [Abstract][Full Text] [Related]
27. Urolithin A promotes mitophagy and suppresses NLRP3 inflammasome activation in lipopolysaccharide-induced BV2 microglial cells and MPTP-induced Parkinson's disease model. Qiu J; Chen Y; Zhuo J; Zhang L; Liu J; Wang B; Sun D; Yu S; Lou H Neuropharmacology; 2022 Apr; 207():108963. PubMed ID: 35065082 [TBL] [Abstract][Full Text] [Related]
28. Ischemia-induced ACSL4 activation contributes to ferroptosis-mediated tissue injury in intestinal ischemia/reperfusion. Li Y; Feng D; Wang Z; Zhao Y; Sun R; Tian D; Liu D; Zhang F; Ning S; Yao J; Tian X Cell Death Differ; 2019 Nov; 26(11):2284-2299. PubMed ID: 30737476 [TBL] [Abstract][Full Text] [Related]
29. Isoliquiritigenin inhibits microglia-mediated neuroinflammation in models of Parkinson's disease via JNK/AKT/NFκB signaling pathway. Bai Y; Zhou J; Zhu H; Tao Y; Wang L; Yang L; Wu H; Huang F; Shi H; Wu X Phytother Res; 2023 Mar; 37(3):848-859. PubMed ID: 36484427 [TBL] [Abstract][Full Text] [Related]
30. α-Asarone attenuates microglia-mediated neuroinflammation by inhibiting NF kappa B activation and mitigates MPTP-induced behavioral deficits in a mouse model of Parkinson's disease. Kim BW; Koppula S; Kumar H; Park JY; Kim IW; More SV; Kim IS; Han SD; Kim SK; Yoon SH; Choi DK Neuropharmacology; 2015 Oct; 97():46-57. PubMed ID: 25983275 [TBL] [Abstract][Full Text] [Related]
31. Investigating Therapeutic Effects of Indole Derivatives Targeting Inflammation and Oxidative Stress in Neurotoxin-Induced Cell and Mouse Models of Parkinson's Disease. Chiu YJ; Lin CH; Lin CY; Yang PN; Lo YS; Chen YC; Chen CM; Wu YR; Yao CF; Chang KH; Lee-Chen GJ Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768965 [TBL] [Abstract][Full Text] [Related]
32. Liver-specific knockdown of long-chain acyl-CoA synthetase 4 reveals its key role in VLDL-TG metabolism and phospholipid synthesis in mice fed a high-fat diet. Singh AB; Kan CFK; Kraemer FB; Sobel RA; Liu J Am J Physiol Endocrinol Metab; 2019 May; 316(5):E880-E894. PubMed ID: 30721098 [TBL] [Abstract][Full Text] [Related]
33. PDCD4 Simultaneously Promotes Microglia Activation via PDCD4-MAPK-NF-κB Positive Loop and Facilitates Neuron Apoptosis During Neuroinflammation. Chen Q; Lu H; Duan C; Zhu X; Zhang Y; Li M; Zhang D Inflammation; 2022 Feb; 45(1):234-252. PubMed ID: 34613548 [TBL] [Abstract][Full Text] [Related]
34. CD73-derived adenosine controls inflammation and neurodegeneration by modulating dopamine signalling. Meng F; Guo Z; Hu Y; Mai W; Zhang Z; Zhang B; Ge Q; Lou H; Guo F; Chen J; Duan S; Gao Z Brain; 2019 Mar; 142(3):700-718. PubMed ID: 30689733 [TBL] [Abstract][Full Text] [Related]
35. MicroRNA-190 alleviates neuronal damage and inhibits neuroinflammation via Nlrp3 in MPTP-induced Parkinson's disease mouse model. Sun Q; Wang S; Chen J; Cai H; Huang W; Zhang Y; Wang L; Xing Y J Cell Physiol; 2019 Dec; 234(12):23379-23387. PubMed ID: 31232472 [TBL] [Abstract][Full Text] [Related]
36. HIV-1 Tat-mediated microglial ferroptosis involves the miR-204-ACSL4 signaling axis. Kannan M; Sil S; Oladapo A; Thangaraj A; Periyasamy P; Buch S Redox Biol; 2023 Jun; 62():102689. PubMed ID: 37023693 [TBL] [Abstract][Full Text] [Related]
37. Alpha-lipoic acid improved motor function in MPTP-induced Parkinsonian mice by reducing neuroinflammation in the nigral and spinal cord. Zhang J; Wang M; Zhao Y; Zhang Y; Gao Y; Zhang X; Yang G Neurosci Lett; 2022 Jun; 781():136669. PubMed ID: 35490905 [TBL] [Abstract][Full Text] [Related]
38. Neuroprotective Effect of Ceftriaxone on MPTP-Induced Parkinson's Disease Mouse Model by Regulating Inflammation and Intestinal Microbiota. Zhou X; Lu J; Wei K; Wei J; Tian P; Yue M; Wang Y; Hong D; Li F; Wang B; Chen T; Fang X Oxid Med Cell Longev; 2021; 2021():9424582. PubMed ID: 34938384 [TBL] [Abstract][Full Text] [Related]
39. Inhibition of neuroinflammation by MIF inhibitor 3-({[4-(4-methoxyphenyl)-6-methyl-2-pyrimidinyl]thio}1methyl)benzoic acid (Z-312). Zheng LT; Chen J; Zhang L; Zhang Y; Xu L; Hou T; Zhen X; Dai Q; Liu H Int Immunopharmacol; 2021 Sep; 98():107868. PubMed ID: 34153665 [TBL] [Abstract][Full Text] [Related]
40. 2-(5-(4-Chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazol-3-yl)-N-(2-hydroxyethyl)-2-oxoacetamide (CDMPO) has anti-inflammatory properties in microglial cells and prevents neuronal and behavioral deficits in MPTP mouse model of Parkinson's disease. Kim B; Park JY; Cho DY; Ko HM; Yoon SH; Choi DK Neuropharmacology; 2020 Apr; 166():107928. PubMed ID: 31887307 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]